These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10680738)

  • 1. Recent advances in the therapy and prevention of CMV infections.
    Nichols WG; Boeckh M
    J Clin Virol; 2000 Feb; 16(1):25-40. PubMed ID: 10680738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
    Kusne S; Shapiro R; Fung J
    Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocompromised hosts: perspectives in the treatment and prophylaxis of cytomegalovirus disease in solid-organ transplant recipients.
    Torres-Madriz G; Boucher HW
    Clin Infect Dis; 2008 Sep; 47(5):702-11. PubMed ID: 18652557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
    Noble S; Faulds D
    Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy.
    Boeckh M
    Transpl Infect Dis; 1999 Sep; 1(3):165-78. PubMed ID: 11428987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients.
    Len O; Gavaldà J; Aguado JM; Borrell N; Cervera C; Cisneros JM; Cuervas-Mons V; Gurguí M; Martin-Dávila P; Montejo M; Muñoz P; Bou G; Carratalà J; Torre-Cisneros J; Pahissa A;
    Clin Infect Dis; 2008 Jan; 46(1):20-7. PubMed ID: 18171208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the diagnosis and treatment of infections caused by herpesvirus and JC virus].
    Arribas JR; Arrizabalaga J; Mallolas J; López-Cortés LF
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():11-9. PubMed ID: 9859615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
    Hebart H; Kanz L; Jahn G; Einsele H
    Drugs; 1998 Jan; 55(1):59-72. PubMed ID: 9463790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.
    Zaia JA
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S392-9. PubMed ID: 8274605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.
    Casillo R; Grimaldi M; Ragone E; Maiello C; Marra C; De Santo L; Amarelli C; Romano G; Della Corte A; Portella G; Tripodi MF; Fortunato R; Cotrufo M; Utili R
    Transplant Proc; 2004 Apr; 36(3):651-3. PubMed ID: 15110622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy preemptive therapy with ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients].
    López-Medrano F; Lumbreras C; Otero JR; González-Alegre MT; San Juan R; Folgueira D; Lizasoaín M; Loinaz C; Moreno E; Aguado JM
    Med Clin (Barc); 2004 Jan; 122(2):41-5. PubMed ID: 14733853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
    Winston DJ; Ho WG; Bartoni K; Holland GN; Mitsuyasu RT; Gale RP; Busuttil RW; Champlin RE
    Rev Infect Dis; 1988; 10 Suppl 3():S547-53. PubMed ID: 2847292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update (1995) on clinical trials of antiviral therapy and prophylaxis for AIDS-related cytomegalovirus disease.
    Jacobson MA
    Scand J Infect Dis Suppl; 1995; 99():96-9. PubMed ID: 8668951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.
    Platzbecker U; Bandt D; Thiede C; Helwig A; Freiberg-Richter J; Schuler U; Plettig R; Geissler G; Rethwilm A; Ehninger G; Bornhäuser M
    Transplantation; 2001 Apr; 71(7):880-5. PubMed ID: 11349720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
    Hodson EM; Barclay PG; Craig JC; Jones C; Kable K; Strippoli GF; Vimalachandra D; Webster AC
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003774. PubMed ID: 16235341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.
    Razonable RR; Humar A
    Clin Transplant; 2019 Sep; 33(9):e13512. PubMed ID: 30817026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
    Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
    Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.
    Bacigalupo A; Boyd A; Slipper J; Curtis J; Clissold S
    Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1249-64. PubMed ID: 23167560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.